LGCCX
Price
$19.29
Change
+$0.10 (+0.52%)
Updated
Sep 26 closing price
Net Assets
307.72M
RWIBX
Price
$73.53
Change
+$0.30 (+0.41%)
Updated
Sep 26 closing price
Net Assets
140.16B
Interact to see
Advertisement

LGCCX vs RWIBX

Header iconLGCCX vs RWIBX Comparison
Open Charts LGCCX vs RWIBXBanner chart's image
Lord Abbett Global Equity C
Price$19.29
Change+$0.10 (+0.52%)
VolumeN/A
Net Assets307.72M
American Funds Capital World Gr&Inc R2
Price$73.53
Change+$0.30 (+0.41%)
VolumeN/A
Net Assets140.16B
LGCCX vs RWIBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGCCX vs. RWIBX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGCCX is a Buy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 140B vs. LGCCX (308M). RWIBX pays higher dividends than LGCCX: RWIBX (0.80) vs LGCCX (0.00). LGCCX was incepted earlier than RWIBX: LGCCX (9 years) vs RWIBX (23 years). LGCCX (2.47) is less costly to investors than RWIBX (1.51). LGCCX is a more actively managed with annual turnover of: 41.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than LGCCX: RWIBX (250) vs LGCCX (1500). LGCCX annual gain was more profitable for investors over the last year : 15.79 vs. RWIBX (8.53). LGCCX return over 5 years is better than : 58.52 vs. RWIBX (50.60).
LGCCXRWIBXLGCCX / RWIBX
Total Expense Ratio1.651.51109%
Annual Report Gross Expense Ratio2.471.51164%
Fund Existence9 years23 years-
Gain YTD17.47918.18696%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets308M140B0%
Annual Yield % from dividends0.000.80-
Returns for 1 year15.798.53185%
Returns for 3 years80.6766.20122%
Returns for 5 years58.5250.60116%
Returns for 10 yearsN/A84.28-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETAHX39.570.43
+1.10%
Eventide Healthcare & Life Sciences A
FCVIX20.260.20
+1.00%
Fidelity Advisor Small Cap Value I
GMVIX16.910.16
+0.96%
Goldman Sachs Small/Mid Cap Equity Inv
WSHCX65.480.42
+0.65%
American Funds Washington Mutual C
JDVAX16.890.07
+0.42%
JPMorgan Diversified A